Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02523859Phase 3Terminated
A Phase 3 trial of remimazolam in general anesthesia, sponsored by PAION AG. Started Jul 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02523859.